Topics in this issue include:

• Focus on Fraud and Abuse: Recent Fraud and Abuse Developments in the Pharmaceutical Industry
  New Standards for Brady and Giglio Disclosures
  The European Commission Sector Inquiry Into Pharmaceuticals: A Shot in the Arm for Generics?
  Some Lessons Learned and Not to Learn for All Healthcare Organizations from the Recent Implant Device Deferred Prosecution Agreements
  Medication Smuggling and Safety Policy in Colombia
• Other Developments
  Pro Bono Medical Device Client Wins Grant from State of Texas